Chimiotaxie des leucocytes < Chimiothérapie d'induction < Chimiothérapie de consolidation

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Chimiothérapie d'induction

Number of relevant bibliographic references: 13.

Ident.	Authors (with country if any)	Title
000913 (2019)	Carlotta Nannini [Italie] ; Laura Niccoli [Italie] ; Stelvio Sestini [Italie] ; Iashar Laghai [Italie] ; Angela Coppola [Italie] ; Fabrizio Cantini [Oman]	Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study.
000B65 (2019)	Maxime Ma Verhoeven [Pays-Bas] ; Marjolein Jh De Hair [Pays-Bas] ; Janneke Tekstra [Pays-Bas] ; Johannes Wj Bijlsma [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Attila Pethoe-Schramm [Suisse] ; Michelle Ea Borm [Pays-Bas] ; Evert-Jan Ter Borg [Pays-Bas] ; Suzanne P. Linn-Rasker [Pays-Bas] ; Xavier M. Teitsma [Pays-Bas] ; Floris Pjg Lafeber [Pays-Bas] ; Johannes Wg Jacobs [Pays-Bas] ; Paco Mj Welsing [Pays-Bas]	Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
000C57 (2019)	John H. Stone ; Katie Tuckwell ; Sophie Dimonaco ; Micki Klearman ; Martin Aringer ; Daniel Blockmans ; Elisabeth Brouwer ; Maria C. Cid ; Bhaskar Dasgupta ; Juergen Rech ; Carlo Salvarani ; Hendrik Schulze-Koops ; Georg Schett ; Robert Spiera ; Sebastian H. Unizony ; Neil Collinson	Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab
000E34 (2019)	Takahiko Akagi [Japon] ; Shunichi Fujita [Japon] ; Tomoyuki Mukai [Japon] ; Yoshitaka Morita [Japon]	Complete resolution of giant cell arteritis after tocilizumab monotherapy determined by positron emission tomography-CT.
001198 (2018)	Lianne Kearsley-Fleet [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]	Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
001350 (2018)	Andrea D. Gloor [Suisse] ; Daniel Yerly [Suisse] ; Sabine Adler [Suisse] ; Stephan Reichenbach [Suisse] ; Stefan Kuchen [Suisse] ; Michael Seitz [Suisse] ; Peter M. Villiger [Suisse]	Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritis.
001455 (2018)	Pavel I. Novikov [Russie] ; Ilya O. Smitienko [Russie] ; Maria V. Sokolova [Russie] ; Fatma Alibaz-Oner [Turquie] ; Sema Kaymaz-Tahra [Turquie] ; Haner Direskeneli [Turquie] ; Sergey V. Moiseev [Russie]	Certolizumab pegol in the treatment of Takayasu arteritis.
001999 (2016)	Peter M. Villiger [Suisse] ; Sabine Adler [Suisse] ; Stefan Kuchen [Suisse] ; Felix Wermelinger [Suisse] ; Diana Dan [Suisse] ; Veronika Fiege [Suisse] ; Lukas Bütikofer [Suisse] ; Michael Seitz [Suisse] ; Stephan Reichenbach [Suisse]	Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
001D57 (2016)	Mats Jerkeman [Suède] ; Ola Lindén [Suède]	Long‐term remission in idiopathic Castleman's disease with tocilizumab followed by consolidation with high‐dose melphalan—two case studies
002484 (2014)	T W J. Huizinga [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin-Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Maher Aassi ; Corrado Bernasconi ; Maxime Dougados [France]	Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study
002643 (2013)	L. Sailler [France] ; G. Pugnet ; B. Bienvenu	[Treatment of giant cell arteritis].
004312 (????)	Daniela Santos-Faria ; José Tavares-Costa ; M Nica Eusébio ; Joana Leite Silva ; Joana Ramos Rodrigues ; Joana Sousa-Neves ; Ana Catarina Duarte ; Carina Lopes ; Ana Valido ; Joana Dinis ; João Freitas ; Mariana Santiago ; Raquel Ferreira ; Sara Ganhão ; Luís Miranda ; Daniela Peixoto ; Filipa Teixeira ; Sérgio Alcino ; Carmo Afonso ; Maria José Santos	Tocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor in rheumatoid arthritis patients who discontinued a first TNF inhibitor.
004326 (????)	Juan P. Vinicki [Espagne] ; Rosario García-Vicu A [Espagne] ; Miguel Arredondo [Espagne] ; Juan P. L Pez-Bote [Espagne] ; Jesús A. García-Vadillo [Espagne] ; Santos Casta Eda [Espagne] ; José M. Álvaro-Gracia [Espagne]	Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Chimiothérapie d'induction" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Chimiothérapie d'induction" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Chimiothérapie d'induction
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021